Tandem Diabetes Care (TNDM) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $125.9 million.
- Tandem Diabetes Care's Receivables - Net rose 1749.45% to $125.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.9 million, marking a year-over-year increase of 1749.45%. This contributed to the annual value of $121.8 million for FY2024, which is 1542.42% up from last year.
- According to the latest figures from Q3 2025, Tandem Diabetes Care's Receivables - Net is $125.9 million, which was up 1749.45% from $128.4 million recorded in Q2 2025.
- In the past 5 years, Tandem Diabetes Care's Receivables - Net ranged from a high of $128.4 million in Q2 2025 and a low of $77.2 million during Q1 2021
- Its 5-year average for Receivables - Net is $104.8 million, with a median of $103.8 million in 2022.
- In the last 5 years, Tandem Diabetes Care's Receivables - Net surged by 6651.86% in 2021 and then crashed by 1106.95% in 2023.
- Tandem Diabetes Care's Receivables - Net (Quarter) stood at $115.0 million in 2021, then dropped by 0.22% to $114.7 million in 2022, then decreased by 7.99% to $105.6 million in 2023, then rose by 15.42% to $121.8 million in 2024, then increased by 3.37% to $125.9 million in 2025.
- Its Receivables - Net was $125.9 million in Q3 2025, compared to $128.4 million in Q2 2025 and $126.6 million in Q1 2025.